DrugPatentWatch Database Preview
Profile for Japan Patent: 2013209426
US Patent Family Members and Approved Drugs for Japan Patent: 2013209426
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Jul 31, 2026 | Takeda Pharms Usa | ACTOPLUS MET XR | metformin hydrochloride; pioglitazone hydrochloride |
➤ Sign Up | Sep 19, 2023 | Takeda Pharms Usa | ACTOPLUS MET XR | metformin hydrochloride; pioglitazone hydrochloride |
➤ Sign Up | Sep 19, 2023 | Takeda Pharms Usa | ACTOPLUS MET XR | metformin hydrochloride; pioglitazone hydrochloride |
➤ Sign Up | Jul 31, 2026 | Takeda Pharms Usa | ACTOPLUS MET XR | metformin hydrochloride; pioglitazone hydrochloride |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |